The Pediatric Preclinical Testing Program (PPTP): changing the paradigm for drug development

被引：0
|
作者：
Houghton, P. [1 ]
机构：
[1] St Jude Childrens Hosp, Memphis, TN 38105 USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)71944-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Testing program approaches to evaluating new agents - The Pediatric Preclinical Testing Program (PPTP)
    Smith, M.
    [J]. EJC SUPPLEMENTS, 2006, 4 (12): : 77 - 78
  • [2] Pediatric Preclinical Testing Program (PPTP) stage I evaluation of cabozantinib
    Smith, Malcolm
    Kang, Min
    Reynolds, Patrick
    Gorlick, Richard
    Kolb, Anders
    Maris, John
    Keir, Stephen
    Billups, Catherine
    Kurmasheva, Raushan
    Houghton, Peter
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [3] Pediatric Preclinical Testing Program (PPTP) Stage 1 Evaluation of Eribulin
    Smith, M.
    Kang, M.
    Lock, R.
    Carol, H.
    Gorlick, R.
    Kolb, A.
    Maris, J.
    Keir, S.
    Kurmasheva, R.
    Houghton, P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : 105 - 105
  • [4] Pediatric Preclinical Testing Program (PPTP) evaluation of PR-104
    Morton, Christopher
    Houghton, Peter
    Maris, John
    Courtright, Joshua
    Kolb, E.
    Gorlick, Richard
    Carol, Hernan
    Lock, Richard
    Friedman, Henry
    Keir, Stephen
    Kang, Min
    Reynolds, C.
    Smith, Malcolm
    [J]. CANCER RESEARCH, 2009, 69
  • [5] The Pediatric Preclinical Testing Program (PPTP): Analysis of the first 10 years in vivo testing
    Houghton, P.
    Lock, R.
    Carol, H.
    Gorlick, R.
    Kolb, A.
    Maris, J.
    Keir, S.
    Wu, J.
    Kang, M.
    Reynolds, P.
    Kurmasheva, R.
    Smith, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 131 - 132
  • [6] Pediatric preclinical testing program (PPTP) evaluation of the DNA methylating agent temozolomide
    Keir, Stephen T.
    Morton, Christopher L.
    Kolb, E. Anders
    Gorlick, Richard
    Caroi, Hernan
    Lock, Richard
    Kang, Min H.
    Reynolds, C. Patrick
    Maris, John M.
    Wu, Jianrong
    Smith, Malcolm A.
    Houghton, Peter J.
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Pediatric preclinical testing program (PPTP) evaluation of the Akt inhibitor GSK690693
    Carol, Hernan
    Lock, Richard
    Houghton, Peter
    Morton, Christopher
    Maris, John
    Courtright, Joshua
    Kolb, E.
    Gorlick, Richard
    Friedman, Henry
    Keir, Stephen
    Kang, Min
    Reynolds, C.
    Smith, Malcolm
    [J]. CANCER RESEARCH, 2009, 69
  • [8] Initial Testing of the Aurora Kinase A Inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)
    Maris, John M.
    Morton, Christopher L.
    Gorlick, Richard
    Kolb, E. Anders
    Lock, Richard
    Carol, Hernan
    Keir, Stephen T.
    Reynolds, C. Patrick
    Kang, Min H.
    Wu, Jianrong
    Smith, Malcolm A.
    Houghton, Peter J.
    [J]. PEDIATRIC BLOOD & CANCER, 2010, 55 (01) : 26 - 34
  • [9] Pediatric Preclinical Testing Program (PPTP) stage 1 evaluation of Glembatumumab Vedotin.
    Gorlick, Richard
    Kolb, Anders
    Wu, Jainrong
    Kurmasheva, Raushan
    Hawthorne, Thomas
    Houghton, Peter
    Smith, Malcolm
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [10] Evaluation of bortezomib against childhood tumor models by the pediatric preclinical testing program (PPTP)
    Houghton, PJ
    Maris, JM
    Friedman, HS
    Keir, ST
    Lock, RB
    Gorlick, R
    Kolb, EA
    Reynolds, CP
    Morton, C
    Smith, MA
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8987S - 8988S
12345